An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

Completed

Conditions studied: Relapsed/Refractory Acute Lymphoblastic Leukemia

In brief

A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in the US.

Key facts

Study ID

NCT02783651

Run by

Amgen

People needed

212

Starts

2016-06-30

Expected to finish

2020-03-31

Last updated by the study team

2020-04-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medical records of patients initiating treatment for Ph- R/R ALL at participating clinical centers in the US between January 2013 and March 2019 will be eligible for inclusion.

You may not qualify if…

• Medical records of patients with Ph+ ALL will be excluded.
• If informed consent is required, medical records of patients who do not provide informed consent will be excluded.

Where it is running

• Research Site — Tucson, Arizona, United States
• Research Site — Duarte, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Ames, Iowa, United States
• Research Site — New Orleans, Louisiana, United States
• Research Site — Baltimore, Maryland, United States
• Research Site — Baltimore, Maryland, United States
• Research Site — Detroit, Michigan, United States
• Research Site — Hackensack, New Jersey, United States
• Research Site — Buffalo, New York, United States
• Research Site — New York, New York, United States
• Research Site — Winston-Salem, North Carolina, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Cleveland, Ohio, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Austin, Texas, United States
• Research Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.